Wellgistics Health, Inc. Signs Material Definitive Agreement
Ticker: WGRX · Form: 8-K · Filed: Oct 1, 2025 · CIK: 2030763
Sentiment: neutral
Topics: material-agreement, company-name-change
TL;DR
Wellgistics Health (formerly Danam Health) signed a big deal on 9/25/25.
AI Summary
On September 25, 2025, Wellgistics Health, Inc. entered into a material definitive agreement. The company, formerly known as Danam Health, Inc. until July 17, 2024, is headquartered in Tampa, Florida.
Why It Matters
This filing indicates a significant new contract or partnership for Wellgistics Health, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, the specifics of which are not detailed in this initial 8-K filing.
Key Players & Entities
- Wellgistics Health, Inc. (company) — Registrant
- Danam Health, Inc. (company) — Former company name
- September 25, 2025 (date) — Date of earliest event reported
- July 17, 2024 (date) — Date of name change
- 3000 Bayport Drive Suite 950 Tampa, FL 33607 (location) — Principal executive offices address
FAQ
What is the nature of the material definitive agreement entered into by Wellgistics Health, Inc.?
The filing does not specify the details of the material definitive agreement, only that one was entered into on September 25, 2025.
When did Wellgistics Health, Inc. change its name from Danam Health, Inc.?
The company changed its name from Danam Health, Inc. on July 17, 2024.
What is the principal executive office address for Wellgistics Health, Inc.?
The principal executive offices are located at 3000 Bayport Drive Suite 950, Tampa, FL 33607.
What is the SIC code for Wellgistics Health, Inc.?
The Standard Industrial Classification (SIC) code for Wellgistics Health, Inc. is 5122, which corresponds to Wholesale - Drugs, Proprietaries & Druggists' Sundries.
What is the filing date of this 8-K report?
This 8-K report was filed as of October 1, 2025.
Filing Stats: 1,830 words · 7 min read · ~6 pages · Grade level 12.8 · Accepted 2025-10-01 17:21:52
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share WGRX The Nasdaq Stock Mar
- $0.70 — re (the " Common Stock ") at a price of $0.70 per share and (ii) warrants to purchase
- $5 million — eeds from the Offering of approximately $5 million before deducting placement agent fees a
- $350,000 — paid the Placement Agent a cash fee of $350,000, equal to seven percent (7%) of the gro
- $100,000 — tion with the Offering in the amount of $100,000, and clearing expenses equal to $15,950
- $15,950 — 100,000, and clearing expenses equal to $15,950. As additional consideration, the Compa
- $0 — iately at a per share exercise price of $0.875, subject to adjustment as set forth
Filing Documents
- form8-k.htm (8-K) — 54KB
- ex4-1.htm (EX-4.1) — 129KB
- ex4-2.htm (EX-4.2) — 142KB
- ex10-1.htm (EX-10.1) — 251KB
- ex99-1.htm (EX-99.1) — 13KB
- ex99-2.htm (EX-99.2) — 25KB
- 0001493152-25-016562.txt ( ) — 907KB
- wgrx-20250925.xsd (EX-101.SCH) — 3KB
- wgrx-20250925_lab.xml (EX-101.LAB) — 33KB
- wgrx-20250925_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Wellgistics Health, Inc. Dated: October 1, 2025 By: /s/ Mark DiSiena Mark DiSiena Chief Financial Officer